Changes in the expression of cytochromes P450 and nuclear receptors in the liver of genetically diabetic db/db mice.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1248/BPB.29.1634PMID 16880618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatic CYP3A Expression is Attenuated in Obese Mice Fed a High-Fat Diet

  2006cited by this paper
• Structural Determinants of Constitutive Androstane Receptor Required for Its Glucocorticoid Receptor Interacting Protein-1-mediated Nuclear Accumulation*

  2005cited by this paper
• Expression and induction of cytochrome P 450 s in rat white adipose tissue

  2004cited by this paper
• Induction of Drug Metabolism: The Role of Nuclear Receptors

  2003cited by this paper
• Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor CAR.

  2003cited by this paper
• Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass*

  2003cited by this paper
• Genetic polymorphism of human cytochrome p450 involved in drug metabolism.

  2002cited by this paper
• Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression

  2002cited by this paper
• Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital.

  2002cited by this paper
• Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYB2B1 gene by phenobarbital in rat livers.

  2001cited by this paper
• Hepatic cytochrome P450 regulation in disease states.

  2001cited by this paper
• Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.

  2000cited by this paper
• Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice.

  2000cited by this paper
• Up-Regulation of Peroxisome Proliferator-Activated Receptors (PPAR-α) and PPAR-γ Messenger Ribonucleic Acid Expression in the Liver in Murine Obesity: Troglitazone Induces Expression of PPAR-γ-Responsive Adipose Tissue-Specific Genes in the Liver of Obese Diabetic Mice* * This work was supported by

  2000cited by this paper
• Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes.

  1999cited by this paper
• Effect of leptin on cytochrome P-450, conjugation, and antioxidant enzymes in the ob/ob mouse.

  1999cited by this paper
• Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice

  1999cited by this paper
• Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats.

  1999cited by this paper
• P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

  1999cited by this paper
• Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice.

  1999cited by this paper
• Phenobarbital-Responsive Nuclear Translocation of the Receptor CAR in Induction of the CYP2B Gene

  1999cited by this paper
• Peroxisome proliferator-activated receptors: nuclear control of metabolism.

  1999cited by this paper
• Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation

  1998cited by this paper
• The Leptin Receptor*

  1997cited by this paper
• Abnormal splicing of the leptin receptor in diabetic mice

  1996cited by this paper
• Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice.

  1996cited by this paper
• Leptin receptor missense mutation in the fatty Zucker rat

  1996cited by this paper
• Phenotype of fatty Due to Gln269Pro Mutation in the Leptin Receptor (Lepr)

  1996cited by this paper
• Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line.

  1995cited by this paper
• Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rat.

  1995cited by this paper
• Effect of fasting and obesity in humans on the 6‐hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity

  1994cited by this paper
• Cytochrome P450 2B enzyme (CYP2B) induction defect following phenobarbital treatment in the fa/fa Zucker rat: molecular characterization.

  1993cited by this paper
• Effect of genetic obesity and experimental diabetes on hepatic microsomal mixed function oxidase activities

  1990cited by this paper
• Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats.

  1988cited by this paper
• Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat.

  1987cited by this paper
• Triacylglycerol contents and in vivo lipogenesis of ob/ob, db/db and Avy/a mice.

  1976cited by this paper

• Role of constitutive androstane receptor in developmental toxicology: linking chemical exposure, nutrition, and disease susceptibility.

  2026cites this paper
• 20-HETE: Its potential role in physiological and pathophysiological processes.

  2025cites this paper
• Potential impact of underlying diseases influencing ADME in nonclinical safety assessment.

  2024cites this paper
• Investigation of the Expression of CYP3A4 in Diabetic Rats in Xenobiotic Metabolism

  2023cites this paper
• Schisandra lignans ameliorate nonalcoholic steatohepatitis by regulating aberrant metabolism of phosphatidylethanolamines

  2023cites this paper
• Inhibition of mPGES‐2 ameliorates NASH by activating NR1D1 via heme

  2022cites this paper
• A Transcriptomic Response to Lactiplantibacillus plantarum-KCC48 against High-Fat Diet-Induced Fatty Liver Diseases in Mice

  2022cites this paper
• Cytochrome P450 2E1 (CYP2E1) positively regulates lipid catabolism and induces browning in 3T3-L1 white adipocytes.

  2021cites this paper
• Systems toxicogenomics of prenatal low-dose BPA exposure on liver metabolic pathways, gut microbiota, and metabolic health in mice

  2020cites this paper
• Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment

  2020cites this paper
• Regulation of CAR and PXR Expression in Health and Disease

  2020cites this paper
• Enhancement of acetaminophen-induced chronic hepatotoxicity in spontaneously diabetic torii (SDT) rats.

  2020cites this paper
• Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes

  2020cites this paper
• Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice

  2019cites this paper
• Dietary-induced obesity, hepatic cytochrome P450 and lidocaine metabolism: Comparative effects of high-fat diets in mice and rats and reversibility of effects with normalization of diet.

  2019cites this paper
• Mice depleted for Exchange Proteins Directly Activated by cAMP (Epac) exhibit irregular liver regeneration in response to partial hepatectomy

  2019cites this paper
• Cyp2b-Knockdown Mice Poorly Metabolize Corn Oil and Are Age-Dependent Obese.

  2018cites this paper
• Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: what is the potential clinical significance?

  2018influential citation
• Novel differences in renal gene expression in a diet-induced obesity model.

  2018cites this paper
• High fat diet induced obesity is mitigated in Cyp3a-null female mice.

  2018cites this paper
• The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders

  2018cites this paper
• Hypoglycemic mechanisms of Ganoderma lucidum polysaccharides F31 in db/db mice via RNA-seq and iTRAQ.

  2018cites this paper
• Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver.

  2018cites this paper
• In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice

  2017cites this paper
• THE IMPACT OF OBESITY ON PROTEINS INVOLVED IN DRUG METABOLISM

  2017cites this paper
• Xenobiotic Receptors in the Crosstalk Between Drug Metabolism and Energy Metabolism

  2017cites this paper
• Tubulin alpha 8 is expressed in hepatic stellate cells and is induced in transformed hepatocytes

  2017cites this paper
• Effects of obesity on liver cytochromes P450 in various animal models.

  2017cites this paper
• Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis

  2017cites this paper
• Effets du diabète de type 2 sur l’expression et l’activité des cytochromes P450 hépatiques et extra-hépatiques chez la souris C57BL/6 sous une diète riche en gras

  2017cites this paper
• Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes

  2016cites this paper
• Hepatic expression of cytochrome P450 in Zucker diabetic fatty rats.

  2016cites this paper
• Cyp3a11‐mediated testosterone‐6β‐hydroxylation decreased, while UGT1a9‐mediated propofol O‐glucuronidation increased, in mice with diabetes mellitus

  2016influential citation
• Effects of dietary fish oil on cytochrome P450 3A expression in the liver of SHR/NDmcr-cp (cp/cp) rats, an animal model for metabolic syndrome

  2015cites this paper
• Drug-Metabolizing and Antioxidant Enzymes in Monosodium L-Glutamate Obese Mice

  2015cites this paper
• The Journal of Toxicological Sciences

  2014cites this paper
• Altered Expressions of Hepatic Cyp2b1, Cyp3a, Ugt1a6 and Mdr1 in Non-Alcoholic Fatty Liver Disease in Rats

  2014cites this paper
• EFFECT OF OBESITY ON HEPATIC DRUG METABOLISM

  2013cites this paper
• Pregnancy Represses Induction of Efflux Transporters in Livers of Type I Diabetic Mice

  2013cites this paper
• Effect of breed on fatty acid composition and lipogenic enzyme abundance in the subcutaneous adipose tissue of pigs.

  2013cites this paper
• Drug disposition in pathophysiological conditions.

  2012influential citation
• 20-HETE in neovascularization.

  2012cites this paper
• Topics on Drug Metabolism

  2012cites this paper
• Le cochon d'Inde comme modèle animal de biotransformation des médicaments : caractérisation de la sous-famille des cytochromes P450 2C, du transporteur membranaire MDR1 et des récepteurs nucléaires CAR et PXR

  2012cites this paper
• Altered Drug Metabolism and Transport in Pathophysiological Conditions

  2012influential citation
• Clinical Consequences of Altered Drug Disposition in Obesity

  2012cites this paper
• Cytochrome P450-derived eicosanoids, inflammation, and atherosclerotic cardiovascular disease

  2011cites this paper
• Does hepatic steatosis affect drug metabolizing enzymes in the liver?

  2011influential citation
• In silico, in vitro and in situ models to assess interplay between CYP3A and P-gp.

  2011cites this paper
• XENOSENSOR REGULATION OF ENZYMES AND TRANSPORTERS IN DRUG EXPOSURE AND DISEASE

  2011cites this paper
• Drug metabolism alterations in nonalcoholic fatty liver disease

  2011influential citation
• Crossroads between drug and energy metabolism : role of constitutive androstane receptor and AMP-activated kinase

  2010cites this paper
• Expression and Functional Analysis of Hepatic Cytochromes P450, Nuclear Receptors, and Membrane Transporters in 10- and 25-Week-Old db/db Mice

  2010cites this paper
• Intestinal flora induces the expression of Cyp3a in the mouse liver

  2009cites this paper
• Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney

  2009cites this paper
• Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.

  2009cites this paper
• Altered expression of CYP in TSOD mice: a model of type 2 diabetes and obesity

  2009cites this paper
• Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

  2009cites this paper
• Change in P-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand obese mice with type 2 diabetes.

  2009cites this paper
• The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress Published, JLR Papers in Press, October 21, 2008.

  2009cites this paper
• Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice

  2009cites this paper
• Induction of drug metabolism : role for nuclear receptors

  2008cites this paper
• Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway

  2008cites this paper
• New insights on the xenobiotic-sensing nuclear receptors in liver diseases--CAR and PXR--.

  2008cites this paper
• Metabolic Pathways of Type 2 Diabetes Intersection of Genetics, Transcriptomics, and Metabolite Profiling

  2008cites this paper
• Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity.

  2008cites this paper
• Mechanisms and Outcomes of Drug- and Toxicant-Induced Liver Toxicity in Diabetes

  2007cites this paper
• PPARα‐dependent induction of the energy homeostasis‐regulating nuclear receptor NR1i3 (CAR) in rat hepatocytes: Potential role in starvation adaptation

  2007cites this paper